Correlation Between Artelo Biosciences and Ocuphire Pharma

Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Artelo Biosciences and Ocuphire Pharma, you can compare the effects of market volatilities on Artelo Biosciences and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Ocuphire Pharma.

Diversification Opportunities for Artelo Biosciences and Ocuphire Pharma

0.39

Correlation Coefficient

Artelo Biosciences  Ocuphire Pharma

Weak diversification

The 3 months correlation between Artelo and Ocuphire is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Ocuphire Pharma go up and down completely randomly.

Pair Corralation between Artelo Biosciences and Ocuphire Pharma

Assuming the 90 days horizon Artelo Biosciences is expected to generate 5.89 times more return on investment than Ocuphire Pharma. However, Artelo Biosciences is 5.89 times more volatile than Ocuphire Pharma. It trades about 0.03 of its potential returns per unit of risk. Ocuphire Pharma is currently generating about -0.04 per unit of risk. If you would invest  3.80  in Artelo Biosciences on March 13, 2024 and sell it today you would lose (2.37) from holding Artelo Biosciences or give up 62.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	58.06%
Values	Daily Returns

Artelo Biosciences  vs.  Ocuphire Pharma

Artelo Biosciences

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Artelo Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Artelo Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Ocuphire Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in July 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Artelo Biosciences and Ocuphire Pharma

The main advantage of trading using opposite Artelo Biosciences and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.

The idea behind Artelo Biosciences and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.